{
    "organizations": [],
    "uuid": "93368956505d6927b56b156b12620ac3119aa610",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bellerophon-therapeutics-q1-shr-lo/brief-bellerophon-therapeutics-q1-shr-loss-0-04-idUSL8N1SH5C5",
    "ord_in_thread": 0,
    "title": "BRIEF-Bellerophon Therapeutics Q1 Shr Loss $0.04",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Bellerophon Therapeutics Inc:\n* BELLEROPHON PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* BELLEROPHON THERAPEUTICS Q1 BASIC EARNINGS PER SHARE $0.07\n* BELLEROPHON THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.04 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T20:53:00.000+03:00",
    "crawled": "2018-05-10T16:12:51.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "bellerophon",
        "therapeutic",
        "inc",
        "bellerophon",
        "provides",
        "business",
        "update",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "bellerophon",
        "therapeutic",
        "q1",
        "basic",
        "earnings",
        "per",
        "share",
        "bellerophon",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}